The Phase 2 dose-finding trial (N=338), published in the New England Journal of Medicine in 2023 (DOI: 10.1056/NEJMoa2301972), randomized participants with obesity (BMI 30-50) to retatrutide at doses ranging from 0.5mg to 12mg weekly or placebo over 48 weeks
How We Tested When we test and review a product, we take a holistic approach to deliver well-rounded product recommendationswe take all the more care when discussing supplements like glutathione, using a comprehensive, science-backed approach to ensure product efficacy
Patients should use this medication as prescribed according to their doctor's prescription and never self-adjust doses at home
Make sure to check out GLP-1 Boosters: What Works, What Doesnt, and What to Avoid for a closer look at supplements that make these claims
The most recent estimates are from 2016
Los productos GLP-1 disponibles incluyen formulaciones inyectables (semaglutida, dulaglutida, liraglutida, exenatida) y una formulacin oral (semaglutida, Rybelsus)